Literature DB >> 23576124

[Patient selection and indications for liver transplantation].

C P Strassburg1.   

Abstract

Liver transplantation represents an established component of the therapeutic repertoire for irreversible chronic liver diseases. Liver transplantation is confronted by a shortage of donor allografts as well as by an increasing overall number of potentially useful indications, which leads to a rationing of this therapeutic option. Since December 2006 the priority for liver transplantation is determined by the model for end-stage liver disease (MELD) and not by the length of waiting time. The evaluation of indications which are prioritized according to laboratory values (serum creatine, serum bilirubin and coagulation) and the so-called standard exception categories which have to fulfil specific criteria place increased demands on the interdisciplinary transplantation team, on the evaluation for liver transplantation and the prediction of the success of transplantation required by the Transplantation Act. The establishment and implementation of robust, objective and transparent systems to assess not only preoperative priorities but also postoperative benefits represents a major challenge for transplantation medicine.

Entities:  

Mesh:

Year:  2013        PMID: 23576124     DOI: 10.1007/s00104-012-2418-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  24 in total

1.  Early liver transplantation for severe alcoholic hepatitis.

Authors:  Philippe Mathurin; Christophe Moreno; Didier Samuel; Jérôme Dumortier; Julia Salleron; François Durand; Hélène Castel; Alain Duhamel; Georges-Philippe Pageaux; Vincent Leroy; Sébastien Dharancy; Alexandre Louvet; Emmanuel Boleslawski; Valerio Lucidi; Thierry Gustot; Claire Francoz; Christian Letoublon; Denis Castaing; Jacques Belghiti; Vincent Donckier; François-René Pruvot; Jean-Charles Duclos-Vallée
Journal:  N Engl J Med       Date:  2011-11-10       Impact factor: 91.245

2.  Liver transplantation for alcoholic hepatitis.

Authors:  Michael Volk
Journal:  Gastroenterology       Date:  2012-02-22       Impact factor: 22.682

3.  Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.

Authors:  Jens J W Tischendorf; Peter N Meier; Christian P Strassburg; Jürgen Klempnauer; Hartmut Hecker; Michael P Manns; Martin Krüger
Journal:  Scand J Gastroenterol       Date:  2006-10       Impact factor: 2.423

Review 4.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

5.  The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.

Authors:  Tobias J Weismüller; Ahmed Negm; Thomas Becker; Hannelore Barg-Hock; Jürgen Klempnauer; Michael P Manns; Christian P Strassburg
Journal:  Transpl Int       Date:  2009-07-10       Impact factor: 3.782

6.  Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.

Authors:  Tobias J Weismüller; Panagiotis Fikatas; Jan Schmidt; Ana P Barreiros; Gerd Otto; Susanne Beckebaum; Andreas Paul; Markus N Scherer; Hartmut H Schmidt; Hans J Schlitt; Peter Neuhaus; Jürgen Klempnauer; Johann Pratschke; Michael P Manns; Christian P Strassburg
Journal:  Transpl Int       Date:  2010-09-03       Impact factor: 3.782

7.  [Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres].

Authors:  H J Schlitt; M Loss; M N Scherer; T Becker; K-W Jauch; B Nashan; H Schmidt; U Settmacher; X Rogiers; P Neuhaus; C Strassburg
Journal:  Z Gastroenterol       Date:  2011-01-10       Impact factor: 2.000

8.  Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.

Authors:  Jens Rosenau; Nazanin Hooman; Johannes Hadem; Kinan Rifai; Matthias J Bahr; Gunnar Philipp; Hans L Tillmann; Juergen Klempnauer; Christian P Strassburg; Michael P Manns
Journal:  Liver Transpl       Date:  2007-03       Impact factor: 5.799

Review 9.  Management of hepatitis B in liver transplantation patients.

Authors:  Didier Samuel
Journal:  Semin Liver Dis       Date:  2004       Impact factor: 6.115

Review 10.  [Liver transplantation: indications and results].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

View more
  2 in total

Review 1.  HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?

Authors:  Christian P Strassburg
Journal:  Visc Med       Date:  2016-06-20

2.  Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation.

Authors:  Tao Ma; Qing-Shan Li; Yue Wang; Bo Wang; Zheng Wu; Yi Lv; Rong-Qian Wu
Journal:  World J Gastroenterol       Date:  2019-04-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.